The role of electron beam computed tomography for measuring coronary artery atherosclerosis

Current Diabetes Reports

Volumn 4, Issue 1, 2004, Pages 20-25

  Mazzone, Theodore ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ELECTRON BEAM TOMOGRAPHY; HUMAN; METABOLIC SYNDROME X; NON INVASIVE MEASUREMENT; PATHOGENESIS; PREDICTION; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; ANGIOCARDIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; METABOLISM; RADIOGRAPHY;

CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; HUMANS; METABOLIC SYNDROME X; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642329829     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-004-0006-8     Document Type: Review

References (43)

1. Wilson PWF, Kannel WB: Epidemiology of hyperglycemia and atherosclerosis. In Hyperglycemia, Diabetes, and Vascular Disease. Edited by Ruderman N, et al. New York: Oxford University Press; 1992:21-29.
2. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997, 126: 296-306.
3. D'Agostino RB, Grundy S, Sullivan LM, et al.: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286: 180-187.
4. Canto JG, Iskandrian AE: Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA 2003, 290: 947-949.
5. Raggi P: Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am J Cardiol 2001, 87(suppl): 27A-34A.
6. Bostrom K, Watson KE, Horn S, et al.: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91: 1800-1809.
7. Janowitz WR, Agatston AS, Kaplan G, et al.: Differences in prevalence and extent of coronary artery calcium detected by ultralast computed tomography in asymptomatic men and women. Am J Cardiol 1993, 72: 247-254.
8. Newman AB, Naydeck BL, Whittle J: Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol 2002, 22: 424-430.
9. Newman AB, Naydeck BL, Sutton-Tyrell K, et al.: Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 2001, 104: 2679-2684.
10. Colhoun HM, Otvos JD, Rubens MB, et al.: Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002, 51: 1949-1956.
11. Calhoun HM, Scheek LM, Rubens MB, et al.: Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001, 50: 652-659.
12. Goodman WG, Goldin J, Kuizon BD, et al.: Coronary artery calcification in young adults with end stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342: 1478-1483.
13. Schurgin S, Rich S, Mazzone T: increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 2001, 24: 335-338.
14. Wagenknecht LE, Bowden DW, Carr JJ, et al.: Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001, 50: 861-866.
15. Hoff JA, Quinn L, Sevrukov A, et al.: The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 2003, 41: 1008-1012.
16. Hosoi M, Sato T, Yamagami K, et al.: Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care 2002, 25: 696-701.
17. Olson JC, Edmundowicz D, Becker DJ, et al.: Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000, 49: 1571-1578.
18. Qu W, Le TT, Azen SP, et al.: Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 2003, 26: 905-910.
19. Wong ND, Sciammarella MG, Polk D, et al.: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003, 41: 1547-1553.
20. Arad Y, Newstein D, Cader F, et al.: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001, 21: 2051-2058.
21. Falk E, Shah P, Fuster V: Coronary plaque disruption. Circulation 1995, 92: 656-671.
22. Davies MJ: The pathophysiology of acute coronary syndromes. Heart 2000, 83: 361-366.
23. He Z-X, Hedrick TD, Pratt CM, et al.: Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 2000, 101: 244-251.
24. Keelan PC, Bielak LF, Ashai K, et al.: Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001, 104: 412-417.
25. Raggi P, Callister TQ, Cooil B, et al.: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000, 101: 850-855.
26. Arad Y, Spadar LA, Goodman K, et al.: Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000, 36: 1253-1260.
27. Detrano RC, Wong ND, Doherty TM, et al.: Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999, 99: 2633-2638.
28. Kondos GT, Hoff JA, Seyrukov A, et al.: Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003, 107: 2571-2576.
29. O'Rourke RA, Brundage BH, Froelicher VF, et al.: American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000, 102: 126-140.
30. Greenland P, Gaziano M: Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 2003, 349: 465-473.
31. Greenland P, Smith SC, Grundy SM: Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001, 104: 1863-1867.
32. Callister TQ, Raggi P, Cooil B: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998, 339: 1972-1978.
33. Achenbach S, Ropers D, Pohle K, et al.: Influence of lipid-lowering therapy on the progressions of coronary artery calcification. Circulation 2002, 106: 1077-1082.
34. Lange LA, Lange EM, Bielak LF, et al.: Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 2002, 22: 418-423.
35. Valdes AM, Wolfe ML,Tate HC, et al.: Association of traditional risk factors with coronary calcification in persons with a family history of premature coronary heart disease: the study of the inherited risk of coronary atherosclerosis. J Investig Med 2001, 49: 353-361.
36. Peyser PA, Bielak LF, Chu JS, et al.: Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 2002, 106: 304-308.
37. Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002, 288: 321-333.
38. Marsh MM, Walker VR, Curtiss LK, et al.: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1999, 40: 893-900.
39. Rosenfeld ME, Kauser K, Martin-McNulty R, et al.: Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 2002, 164: 251-259.
40. Mikkola TS, Clarkson TB: Estrogen replacement therapy, atherosclerosis, and vascular functions. Cardiovasc Res 2002, 53: 605-619.
41. Akhrass F, Evans AT, Wang Y, et al.: Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2003, in press.
42. Nesto RW: Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999, 22: 1393-1394.
43. Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339: 229-234.